Takehiko Yokomizo Selected Research

Omega-3 Fatty Acids (Omega 3 Fatty Acids)

1/2020	n-3 Fatty Acid and Its Metabolite 18-HEPE Ameliorate Retinal Neuronal Cell Dysfunction by Enhancing Müller BDNF in Diabetic Retinopathy.
10/2019	The roles of omega-3 fatty acids and resolvins in allergic conjunctivitis.
1/2019	Dietary supplementation of omega-3 fatty acid eicosapentaenoic acid does not ameliorate pruritus in murine models of atopic dermatitis and psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takehiko Yokomizo Research Topics

Disease

30	Inflammation (Inflammations) 01/2023 - 08/2002
7	Asthma (Bronchial Asthma) 01/2023 - 10/2005
6	Neoplasms (Cancer) 01/2018 - 12/2005
5	Wounds and Injuries (Trauma) 03/2023 - 06/2014
4	Fibrosis (Cirrhosis) 01/2023 - 05/2006
4	Sepsis (Septicemia) 10/2021 - 01/2017
4	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2020 - 01/2019
3	Reperfusion Injury 02/2024 - 08/2013
3	Macular Degeneration (Age-Related Maculopathy) 01/2023 - 02/2015
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 03/2014
3	Pain (Aches) 01/2022 - 03/2015
3	Hypersensitivity (Allergy) 01/2021 - 06/2010
3	Insulin Resistance 01/2020 - 06/2003
3	Atopic Dermatitis (Atopic Eczema) 07/2019 - 01/2019
3	Colitis 01/2018 - 12/2010
3	Leukemia 01/2018 - 11/2002
2	Neuroinflammatory Diseases 12/2023 - 12/2014
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2023 - 04/2010
2	Allergic Contact Dermatitis 01/2023 - 01/2021
2	Immune System Diseases (Immune Disorders) 01/2023 - 10/2005
2	Glomerulonephritis 01/2023 - 01/2023
2	Ischemia 12/2021 - 08/2013
2	Obesity 10/2020 - 06/2003
2	Allergic Rhinitis 07/2019 - 01/2018
2	Anaphylaxis (Anaphylactic Shock) 07/2019 - 10/2016
2	Ureteral Obstruction 01/2019 - 01/2019
2	Eosinophilia 08/2013 - 03/2013
1	Dry Eye Syndromes (Dry Eye Syndrome) 03/2024
1	Ischemic Stroke 02/2024
1	Neurologic Manifestations (Neurological Manifestations) 12/2023
1	Multiple Sclerosis 12/2023
1	Disease Progression 08/2023
1	Patent Ductus Arteriosus 08/2023
1	Bipolar Disorder (Manic Depressive Psychosis) 07/2023
1	Mood Disorders (Mood Disorder) 07/2023
1	Conjunctivitis 01/2023
1	Hyperplasia 01/2023
1	Food Hypersensitivity (Food Allergy) 01/2023
1	Enteritis 01/2023
1	Dermatitis 01/2022
1	Nociceptive Pain 01/2022

Drug/Important Bio-Agent (IBA)

26	Leukotriene B4IBA 01/2023 - 08/2002
18	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 01/2023 - 10/2005
14	LipidsIBA 01/2023 - 09/2005
6	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2024 - 10/2004
6	CytokinesIBA 01/2023 - 06/2010
5	LeukotrienesIBA 07/2019 - 12/2015
4	EnzymesIBA 07/2023 - 11/2002
4	Fatty Acids (Saturated Fatty Acids)IBA 12/2021 - 01/2018
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2020 - 01/2019
3	AcidsIBA 01/2019 - 03/2013
3	12-hydroxy-5,8,10-heptadecatrienoic acidIBA 10/2017 - 06/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2014 - 05/2006
2	Ophthalmic Solutions (Eye Drops)IBA 03/2024 - 10/2017
2	Fingolimod Hydrochloride (FTY720)FDA Link 12/2023 - 12/2014
2	ProstaglandinsIBA 08/2023 - 01/2021
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 07/2023 - 12/2021
2	Eicosapentaenoic AcidIBA 07/2023 - 01/2019
2	Chemotactic FactorsIBA 01/2023 - 01/2015
2	OvalbuminIBA 01/2023 - 08/2013
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2023 - 01/2023
2	Formaldehyde (Formol)FDA Link 01/2022 - 03/2015
2	Phospholipids (Phosphatides)FDA LinkGeneric 12/2021 - 01/2018
2	EicosanoidsIBA 09/2021 - 11/2020
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2021 - 01/2020
2	AntigensIBA 01/2021 - 10/2012
2	AllergensIBA 01/2021 - 03/2013
2	PapaverineIBA 12/2020 - 01/2019
2	Receptor for Advanced Glycation End ProductsIBA 12/2020 - 01/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2020 - 01/2018
2	Anesthetics (Anesthetic Agents)IBA 11/2019 - 01/2017
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2019 - 06/2014
2	Messenger RNA (mRNA)IBA 01/2018 - 08/2013
2	Dextran SulfateIBA 01/2018 - 02/2015
2	Carrier Proteins (Binding Protein)IBA 12/2016 - 01/2016
2	CalciumIBA 01/2016 - 08/2008
2	LipopolysaccharidesIBA 12/2015 - 12/2009
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2024
1	diquafosolIBA 03/2024
1	Fluorescein (Funduscein)FDA LinkGeneric 03/2024
1	Bicarbonates (Hydrogen Carbonate)IBA 02/2024
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2023
1	Transcobalamins (Transcobalamin II)IBA 12/2023
1	VitaminsIBA 12/2023
1	Fatty Acid DesaturasesIBA 07/2023
1	Docosahexaenoic AcidsIBA 07/2023
1	SW033291IBA 03/2023
1	Peroxidase (Myeloperoxidase)IBA 01/2023
1	PotassiumIBA 01/2023
1	Immunoglobulin E (IgE)IBA 01/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023
1	AluminumIBA 01/2023
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	Liver X ReceptorsIBA 01/2022
1	CreatinineIBA 12/2021
1	Soybean Oil FDA LinkGeneric 12/2021
1	Urea (Carbamide)FDA LinkGeneric 12/2021

Therapy/Procedure

4	Ligation 11/2019 - 01/2016
3	Punctures 11/2019 - 01/2017
1	Investigational Therapies (Experimental Therapy) 02/2024